Idiopathic Thrombocytopenic Purpura

Treatments Covered

  • Aczone
  • Aristocort
  • Azasan
  • Azathioprine
  • Betamethasone
  • Carimune
  • Celestone
  • Cellcept
  • Chlorambucil
  • Colchicine
  • Colcrys
  • Cortef
  • Cortisone Acetate
  • Cyclophosphamide
  • Cyclosporine
  • Cycophosphamide Intra Sol
  • Cytoxan
  • Danazol
  • Dapsone
  • Decadron
  • Deltasone
  • Depo-medrol
  • Dexamethasone
  • Doptelet
  • Econopred
  • Gammagard
  • Gammaked
  • Gamunex
  • Gengraf
  • Hydrocort
  • Hyperrho S/d
  • Imuran
  • Leukeran
  • Methylprednisolone
  • Meticorten
  • Micrhogam
  • Mitigare
  • Neoral
  • Nplate
  • Octagam
  • Orapred
  • Panzyga
  • Pediapred
  • Polygam S/d
  • Pred Forte
  • Prednisolone
  • Prednisone
  • Privigen
  • Promacta
  • Rhogam
  • Rhophylac
  • Rituxan
  • Rituxan Hycela
  • Rituximab
  • Ruxience
  • Sandimmune
  • Solu-medrol
  • Sterapred
  • Taperdex
  • Tavalisse
  • Triamcinolone
  • Truxima
  • Vincasar Pfs
  • Vincristine
  • Winrho
  • Winrho Sdf

Fund Definition

Assistance with the prescription drugs and biologics used in the treatment of idiopathic or immune thrombocytopenic purpura.

Grant Utilization

HealthWell estimates that patients use an average of $2,300 during their 12-month grant period for this disease area.

Given the volume of grants that go unused in the ITP fund, we are requiring a first fill within 30 days of approval.  If there is no payment activity on the grant within this time frame, the grant balance will be zeroed out.

Grant funds will not be specifically held for the patient and any future requests for payments will made based on availability of funding and cannot be guaranteed. Before moving forward with the approval process, please be sure you have a valid prescription for the patient that you are confident will be filled within 30 days of approval.

Consider Premium Assistance

Under this fund, HealthWell can assist with premium costs. Medicare supplemental policies can help with cost shares related to many aspects of your health care. Using a HealthWell grant to cover premiums may be a better option than treatment-specific cost shares.

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • 1. You are being treated for Idiopathic Thrombocytopenic Purpura.

    Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • 2. You have insurance and it covers your medication.

    To qualify for assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.

  • 3. Your income falls within our guidelines.
    HealthWell assists individuals with incomes up to 400-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
  • 4. You are receiving treatment in the United States.

    If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.


About Idiopathic Thrombocytopenic Purpura

Idiopathic thrombocytopenic purpura (ITP) is a disorder that can lead to easy or excessive bruising and bleeding. The bleeding results from unusually low levels of platelets — the cells that help your blood clot. Source: Mayo Clinic


Close menu